Showing results (2211-2220 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1983
Phase I trial with 4'-deoxydoxorubicin (esorubicin)M Rozencweig, N Crespeigne, Y KenisInvestigational New Drugs|January 1, 1983
Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group studyF E Smith, N Gad-el-Mawla, B Tranum, et al.Investigational New Drugs|January 1, 1983
Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot studyC D Haas, C J Fabian, R L Stephens, et al.Investigational New Drugs|January 1, 1983
Pharmacokinetics of 4'-epi-doxorubicin in manH Weenen, J Lankelma, P G Penders, et al.Investigational New Drugs|January 1, 1996
Comparison of the antitumor activity of gemcitabine and ara-C in a panel of human breast, colon, lung and pancreatic xenograft modelsR L Merriman, L W Hertel, R M Schultz, et al.Investigational New Drugs|January 1, 1996
Gemcitabine and radiosensitization in human tumor cellsD S Shewach, T S LawrenceInvestigational New Drugs|January 1, 1996
Activity of gemcitabine in a human tumor cloning assay as a basis for clinical trials with gemcitabine. San Antonio Drug Development TeamD D Von HoffInvestigational New Drugs|January 1, 1996
Antitumor diarylsulfonylureas: novel agents with unfulfilled promiseP J Houghton, J A HoughtonInvestigational New Drugs|January 1, 1996
Tomudex (ZD1694): from concept to care, a programme in rational drug discoveryA L Jackman, F T Boyle, K R HarrapInvestigational New Drugs|October 25, 2018
Advanced development of ErbB family-targeted therapies in osteosarcoma treatmentWei Wang, Hua-Fu Zhao, Teng-Fei Yao, et al.Pageof 372